Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of precision medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age-related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Jun 29, 2020

Thierry Abribat, Founder and CEO, Amolyt Pharma is developing a portfolio of products of peptides for rare endocrine and metabolic disorders.  Their first project is a peptide hormone that is a parathyroid hormone being developed to treat hypoparathyroidism, a condition most often suffered by middle aged women and likely caused by thyroid surgery when the parathyroid glands are also removed.  The alternate treatment being developed will address the current short term and long term burden these patients are facing with conventional therapy by better managing blood calcium, decreasing elimination of calcium through the kidneys and maintaining bone integrity.

@AmolytPharma

#TherapeuticPeptides #RareDiseases #EndocrineDisease #MetabolicDisease #Endocrinology #Hypoparathyroidism #Hypopara

AmolytPharma.com

Listen to the podcast here.

 

Amolyt